← Leaderboards
Myron S Czuczman
Ctr For Molecular Medicine/Immunology
$2,003,373
Attributed
$2,003,373
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $360.9K · FY2008–13$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,003,373 · 2
By mechanism
R01$1,773,341 · 1
P01$230,032 · 1
Top collaborators
No co-investigators on record.
Most similar at Ctr For Molecular Medicine/Immunology
Same institution · by research overlap
- Robert M Sharkey$7,941,617
- M Jules Mattes$1,208,134
Others in their field
Top investigators on “Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
LymphomaPathway InteractionsDesignLeadMediatingMulticatalytic Endopeptidase ComplexCollaborationsApoptoticGenesInterestClinical TrialsB-Cell Nonhodgkins LymphomaApoptosisChemotherapyBiopsyCellsB-LymphocytesB Lymphoid MalignancyCell LineFutureCancer TherapyBaseB-Cell LymphomasProteasome Inhibition
Grant awards (6)
Targeting the proteasome to overcome therapy resistance in B-NHL$342,247
R01 · FY2013 · CA · contact PI
Targeting the proteasome to overcome therapy resistance in B-NHL$359,271
R01 · FY2012 · CA · contact PI
Targeting the proteasome to overcome therapy resistance in B-NHL$354,594
R01 · FY2011 · CA · contact PI
Targeting the proteasome to overcome therapy resistance in B-NHL$360,883
R01 · FY2010 · CA · contact PI
Targeting the proteasome to overcome therapy resistance in B-NHL$356,346
R01 · FY2009 · CA · contact PI
Mechanisms of Serotherapy of B-Cell Malignancies$230,032
P01 · FY2008 · CA · contact PI